Merck Wins FDA Approval for Oral PCSK9 Drug LIPFENDRA
RAHWAY, N.J., July 16, 2026 Merck has achieved a significant milestone in cardiovascular medicine with the U.S. Food and...
AtaiBeckley
Advertisement
Lilly Acquires AtaiBeckley to Advance Depression Therapies
INDIANAPOLIS and NEW YORK, July 16, 2026 Eli Lilly and Company has announced a definitive agreement to acquire AtaiBeckley...
AtaiBeckley Completes Patient Dosing in Phase 2b VLS-01 TRD Trial
NEW YORK, July 6, 2026 AtaiBeckley Inc. announced that the final patient has been dosed in Elumina, its international...
AtaiBeckley Redomiciles to U.S., Aligning Pharma Strategy
New York | December 30, 2025 — AtaiBeckley Inc., a clinical-stage biopharmaceutical company focused on developing rapid-acting and scalable...
Advertisement
